Clinical features
Presentation
- Oedema — typically pitting, dependent (ankles), facial puffiness on waking, may progress to ascites, pleural effusion, anasarca
- Frothy urine (proteinuria)
- Weight gain
- Fatigue
- Sometimes blood clots present (calf swelling, breathlessness)
- Xanthelasma (lipid deposits)
Laboratory Diagnosis
- 24-hour urine protein >3.5 g (or urine PCR >300, ACR >250)
- Serum albumin <30 g/L
- Hypercholesterolaemia
- Often normal eGFR initially
- Bland sediment (a few cells, no significant haematuria) — if heavy haematuria, suspect nephritic overlap
Work-up
- Bloods: U&E, LFT, lipids, ANA/dsDNA, ANCA, complement (C3, C4), serum free light chains, protein electrophoresis, hep B/C, HIV, anti-PLA2R
- Urine: ACR, PCR, microscopy, BJP
- Imaging: USS kidneys + bladder
- KIDNEY BIOPSY — almost always in adults; not always in children (MCD presumed)
Causes by biopsy diagnosis
Primary
- Minimal change disease — children mostly; ~10% adults
- FSGS — both primary and APOL1-associated
- Membranous nephropathy — anti-PLA2R+ in ~70% primary; commonest adult nephrotic
- IgA nephropathy — usually nephritic, can be nephrotic
- Membranoproliferative glomerulonephritis (MPGN)
Secondary
- Diabetes (commonest overall in adults)
- Lupus (class V membranous lupus nephritis)
- Amyloidosis (AL, AA)
- Light chain deposition disease
- Hepatitis B → membranous
- Hepatitis C → MPGN, cryoglobulinaemia
- HIV → collapsing FSGS
- Drugs: NSAIDs (minimal change), gold/penicillamine (membranous), bisphosphonates (FSGS), lithium
- Solid tumours (membranous as paraneoplastic; >65 yrs — screen)
- Lymphoma → minimal change
- Pre-eclampsia (in pregnancy)
Kidney Vitality is a daily multivitamin developed by a UK Consultant Nephrologist using renal nutrition principles. It contains no added potassium, magnesium, phosphorus or iron, and no herbal blends. See the formulation.
Treatment — general principles
SUPPORTIVE (all patients):
- Salt restriction <5 g/day
- Fluid restriction 1-1.5 L/day if severe oedema
- Loop diuretic (furosemide 40-80 mg, may need 250 mg IV or torasemide; can be poorly absorbed PO due to gut oedema)
- Daily weights; aim for 0.5-1 kg/day loss; avoid AKI from over-diuresis
- ACE inhibitor or ARB — reduces proteinuria 30-40%
- Statin (atorvastatin 20-40 mg) — high CV risk
- Pneumococcal vaccine; consider penicillin V prophylaxis in children
- Vitamin D replacement (urinary loss)
Anticoagulation
- Indicated when albumin <20 g/L (especially membranous)
- Warfarin (target INR 2-3) or apixaban/rivaroxaban
- Continue until albumin >30 g/L sustained
Cause-specific Treatment
- Minimal change disease — prednisolone 1 mg/kg, 12-16 weeks
- FSGS — prednisolone 1 mg/kg, longer course; CNI if no response
- Membranous — rituximab first-line (MENTOR/STARMEN); 'wait and watch' if low-risk
- Lupus nephritis — MMF + steroids ± rituximab/belimumab
- Amyloidosis — chemotherapy for AL; treat underlying inflammation for AA
- Diabetic — RAS blockade + SGLT2i + finerenone
Monitoring and complications
Remission Definitions
- Complete: ACR <30, albumin normal
- Partial: >50% reduction in proteinuria, ACR <300
- Relapse: ACR rises >300 + recurrence of oedema
Follow-up
- Weekly ACR + bloods during active disease
- Monitor for steroid side effects
- Bone protection (calcium + vitamin D + bisphosphonate if long-term steroid)
- PPI cover during steroids
- PCP prophylaxis if heavy immunosuppression
Long-term
- Cardiovascular risk: statin, BP control, smoking, weight, exercise
- Pregnancy planning — pre-eclampsia + relapse risk; refer to obstetric nephrology
- Vaccinations: annual flu, pneumococcal, COVID boosters; live vaccines contraindicated on immunosuppression
- Long-term nephrology follow-up — relapse risk persists for years






